Skip to main content

Table 1 The clinicopathologic factors associated with recurrence/progression in MOGCTs

From: Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution

Variables

No. Patients (%)

Recurrence No

(Rate, %)

P value

Age, years

   

   < 20

26(45.6)

2(3.5)

0.1177

   20-40

28(49.1)

3(5.3)

 

   > 40

3(5.3)

1(1.8)

 

Histological diagnosis

   

   Dysgerminoma

20(35.1)

0(0.0)

< 0.0001

   Immature teratoma

24(42.1)

1(1.8)

 

   Endodermal sinus tumor

8(14.0)

2(3.5)

 

   Choriocarcinoma

4(7.0)

2(3.5)

 

   Mixed germ cell tumor

1(1.8)

1(1.8)

 

Histological diagnosisa

   

   Dysgerminoma

20(35.1)

0(0.00)

0.0716

   Non-dysgerminoma

37(64.9)

6(10.5)

 

Stage

   

   I

38(66.7)

1(1.8)

0.0052b

   II

3(5.2)

0(0.0)

 

   III

15(26.3)

4(7.0)

 

   IV

1(1.8)

1(1.8)

 

Volume of ascites, cc

   

   < 100

33(57.9)

2(3.5)

0.1277

   ≥ 100

24(42.1)

4(7.0)

 

Elevated AFP, ng/ml (n = 46)

   

   < 100

36(78.3)

4(8.7)

0.4089

   ≥ 100

10(21.7)

2(4.4)

 

Beta-hCG (n = 53)

   

   Normal

45(84.9)

3(5.7)

0.0134

   Elevated

8(15.1)

3(5.7)

 
  1. AFP, alpha-fetoprotein; hCG, human gonadotrophic hormone.
  2. a Comparison between two groups.
  3. b Comparison between stage I-II and stage III-IV.